Second Cancer Following Chemotherapy and Radiotherapy: An epidemiological perspective
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 29 (5), 647-655
- https://doi.org/10.3109/02841869009090070
Abstract
Both ionizing radiation and alkylating chemicals are used to treat cancer, and both are themselves carcinogenic. Epidemiological methods of study have provided a substantial amount of information on the long-term risks of the two types of treatment. Radiotherapy appears to increase the risk of a wide range of cancers, but the size of the increase is not substantial. Chemotherapy, in contrast, produces a very large increase in the risk of acute leukaemia, and does not generally appear to produce other types of cancer. Leukaemias following both treatment modalities appear rapidly, while the risk of solid tumours induced by radiotherapy is not manifested until a decade or more has elapsed. There does not seem to be synergy between the two types of therapy in their carcinogenic action. Continued use of the epidemiological approach is essential in risk-benefit evaluation of cancer therapy.Keywords
This publication has 7 references indexed in Scilit:
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- Bone Sarcomas Linked to Radiotherapy and Chemotherapy in ChildrenNew England Journal of Medicine, 1987
- Incidence of second primary tumours among childhood cancer survivorsBritish Journal of Cancer, 1987
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASEThe Lancet, 1987
- Second acute leukemia and other malignancies following treatment for Hodgkin's disease.Journal of Clinical Oncology, 1986